脊髓海绵状血管畸形的治疗策略与预后因素:单中心回顾性队列研究
该单中心回顾性队列研究纳入2004年至2019年治疗的112例脊髓海绵状血管畸形患者,其中73例手术、39例保守治疗,随访至少24个月。手术组中术前病灶≤5 mm、完全髓内病变及蛛网膜下腔出血为预后不良的独立预测因素;保守组中病灶≥10 mm、≥3个节段含铁血黄素沉积及蛛网膜下腔出血为预后不良的显著预测因素。保守治疗患者年出血率为4.3%。
要点
- 蛛网膜下腔出血、病灶大小、形态、含铁血黄素累及范围及运动功能障碍为独立预后危险因素。
- 手术组术前病灶≤5 mm、完全髓内病变及蛛网膜下腔出血预示更差预后。
- 保守组病灶≥10 mm、≥3个节段含铁血黄素沉积及蛛网膜下腔出血预示更差预后。
核心结论
- 蛛网膜下腔出血、病灶大小、形态、含铁血黄素累及范围及运动功能障碍是脊髓海绵状血管畸形预后的独立危险因素。
- 治疗策略应基于这些危险因素并结合临床症状进行平衡。
研究设计与样本
- 单中心回顾性观察性队列研究,纳入2004年1月至2019年12月在该机构治疗的脊髓海绵状血管畸形患者。
- 共112例符合纳入标准,其中73例手术、39例保守治疗,均随访至少24个月。
- 采用多因素logistic回归和Cox回归分析确定临床结局的预后预测因素,神经功能状态按Frankel分级评估。
主要发现
- 手术组中,术前病灶≤5 mm(OR 13.62,95% CI 1.05-175.98,p=0.045)、完全髓内病变(OR 7.48,95% CI 1.39-40.15,p=0.019)及蛛网膜下腔出血(OR 6.26,95% CI 1.13-34.85,p=0.036)为预后不良的独立预测因素。
- 保守组中,病灶≥10 mm(HR 9.77,95% CI 1.18-80.86,p=0.034)、≥3个节段含铁血黄素沉积(HR 13.73,95% CI 1.94-97.16,p=0.009)及蛛网膜下腔出血(HR 13.44,95% CI 2.38-75.87,p=0.003)为预后不良的显著预测因素。
- 保守治疗患者的年出血率为4.3%。
- 平均病灶大小为8.7±5.2 mm。
临床怎么用
- 临床实践中可利用上述参数识别预后不良高风险患者。
- 治疗决策应基于这些危险因素并结合临床症状制定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The authors aimed to identify factors that influence neurological function after treatment in order to facilitate clinician decision-making during treatment of spinal cavernous malformation (SCM) and about when and whether to perform surgical intervention. METHODS: The authors performed a retrospective observational cohort study of patients with SCM who were treated at their institution between January 2004 and December 2019. Multiple logistic and Cox regression analyses were performed to determine the prognostic predictors of clinical outcome. Neurological status was assessed according to Frankel grade. RESULTS: A total of 112 patients met the inclusion criteria, and a minimum 24 months of follow-up was achieved by 73 surgically treated and 39 conservatively treated patients. The mean ± SD lesion size was 8.7 ± 5.2 mm. In the surgically treated group, preoperative lesion size ≤ 5 mm (OR 13.62, 95% CI 1.05-175.98, p = 0.045), complete intramedullary lesion (OR 7.48, 95% CI 1.39-40.15, p = 0.019), and subarachnoid hemorrhage (OR 6.26, 95% CI 1.13-34.85, p = 0.036) were independent predictors of worse outcome. In the conservative treatment group, lesion size ≥ 10 mm (HR 9.77, 95% CI 1.18-80.86, p = 0.034), ≥ 3 segments with hemosiderin deposition (HR 13.73, 95% CI 1.94-97.16, p = 0.009), and subarachnoid hemorrhage (HR 13.44, 95% CI 2.38-75.87, p = 0.003) were significant predictors of worse outcome. The annual hemorrhage rate of the conservatively treated patients was 4.3%. CONCLUSIONS: Subarachnoid hemorrhage, lesion size, morphology, extent of hemosiderin involvement, and motor dysfunction were independent risk factors of prognosis. In clinical practice, these parameters may help to identify patients at high risk for worse outcome. The treatment strategy for patients with SCM should be based on these risk factors and balanced with clinical symptoms.
引用
- Liu T, Li K, Wang Y, et al. Treatment strategies and prognostic factors for spinal cavernous malformation: a single-center retrospective cohort study. J Neurosurg Spine. 2021. PMID: 34665952. doi:10.3171/2021.2.SPINE201664
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。